» Articles » PMID: 2169335

Tumor Promoter-stimulated Mr 92,000 Gelatinase Secreted by Normal and Malignant Human Cells: Isolation and Characterization of the Enzyme from HT1080 Tumor Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 1990 Oct 1
PMID 2169335
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

A Mr 92,000 metalloprotease, originally observed in neutrophils, has been found to be secreted by various normal and malignant cells of fibroblastic, hematopoietic, and epithelial origin. The responsiveness of the various cell types to the tumor promoter phorbol ester (phorbol myristate acetate) to secrete this enzyme and a corresponding Mr 72,000 gelatinase has been determined using gelatin zymograms. The latent zymogen form of the Mr 92,000 enzyme has been purified from phorbol myristate acetate-stimulated HT1080 human fibrosarcoma cells using sequential gelatin-Sepharose affinity chromatography and gel filtration. Selective elution from gelatin-Sepharose allows for a distinct separation of the Mr 92,000 gelatinase from the Mr 72,000 gelatinase. A fraction of the tumor cell derived latent Mr 92,000 enzyme is isolated as an apparent complex with human tissue inhibitor of metalloproteases, which is partially dissociated in sodium dodecyl sulfate and completely dissociated upon reduction of disulfide bonds and upon p-aminophenylmercuric acetate treatment. Organomercurial treatment rapidly allows for autoactivation of the proenzyme to active Mr 83,000 and Mr 75,000 species. At physiological pH, the enzyme rapidly degrades gelatin into small fragments and slowly cleaves native type V collagen at an apparent single site. Native type IV collagen is degraded to a much lesser extent. The NH2-terminal amino acid sequence of the Mr 92,000 proenzyme has been determined and is distinct from the Mr 72,000 gelatinase/type IV collagenase which is constitutively produced by fibroblasts. The Mr 92,000 enzyme is also immunologically distinct from the Mr 72,000 enzyme but immunologically cross-reactive with the neutrophil, high molecular weight gelatinase. The Mr 92,000 enzyme constitutes a distinct member of the matrix metalloprotease family. Its substrate specificity implies a broad physiological role, acting on basement membrane type V collagen as well as on denatured (gelatinized) collagens and thus may be involved in the invasive and migratory phenotype of human cells.

Citing Articles

Let-7f miRNA regulates SDF-1α- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release.

Egea V, Kessenbrock K, Lawson D, Bartelt A, Weber C, Ries C Cell Death Dis. 2021; 12(6):516.

PMID: 34016957 PMC: 8137693. DOI: 10.1038/s41419-021-03789-3.


Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.

Chen J, Ren Z, Zhu M, Khalil R Biochem Pharmacol. 2017; 138:81-95.

PMID: 28506758 PMC: 5516730. DOI: 10.1016/j.bcp.2017.05.005.


TSG101, a tumor susceptibility gene, bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression.

Sai X, Makiyama T, Sakane H, Horii Y, Hiraishi H, Shirataki H BMC Cancer. 2015; 15:933.

PMID: 26608825 PMC: 4660656. DOI: 10.1186/s12885-015-1942-1.


Expression and complex formation of MMP9, MMP2, NGAL, and TIMP1 in porcine myocardium but not in skeletal muscles in male pigs with tachycardia-induced systolic heart failure.

Kiczak L, Tomaszek A, Bania J, Paslawska U, Zacharski M, Noszczyk-Nowak A Biomed Res Int. 2013; 2013:283856.

PMID: 23710440 PMC: 3654659. DOI: 10.1155/2013/283856.


Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Ardi V, Van den Steen P, Opdenakker G, Schweighofer B, Deryugina E, Quigley J J Biol Chem. 2009; 284(38):25854-66.

PMID: 19608737 PMC: 2757987. DOI: 10.1074/jbc.M109.033472.